Free Trial

AtriCure (ATRC) Competitors

AtriCure logo
$38.47 +0.83 (+2.21%)
As of 01/17/2025 04:00 PM Eastern

ATRC vs. ITGR, IART, ATEC, OFIX, SRDX, ANGO, ARAY, RMTI, RSLS, and ABT

Should you be buying AtriCure stock or one of its competitors? The main competitors of AtriCure include Integer (ITGR), Integra LifeSciences (IART), Alphatec (ATEC), Orthofix Medical (OFIX), Surmodics (SRDX), AngioDynamics (ANGO), Accuray (ARAY), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), and Abbott Laboratories (ABT). These companies are all part of the "health care equipment" industry.

AtriCure vs.

Integer (NYSE:ITGR) and AtriCure (NASDAQ:ATRC) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, community ranking, analyst recommendations, media sentiment, dividends, risk, valuation, profitability and institutional ownership.

99.3% of Integer shares are owned by institutional investors. Comparatively, 99.1% of AtriCure shares are owned by institutional investors. 2.0% of Integer shares are owned by insiders. Comparatively, 3.2% of AtriCure shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Integer currently has a consensus price target of $145.44, suggesting a potential upside of 3.22%. AtriCure has a consensus price target of $42.00, suggesting a potential upside of 9.18%. Given AtriCure's stronger consensus rating and higher possible upside, analysts clearly believe AtriCure is more favorable than Integer.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integer
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.89
AtriCure
0 Sell rating(s)
0 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
3.00

AtriCure received 173 more outperform votes than Integer when rated by MarketBeat users. Likewise, 69.17% of users gave AtriCure an outperform vote while only 63.92% of users gave Integer an outperform vote.

CompanyUnderperformOutperform
IntegerOutperform Votes
388
63.92%
Underperform Votes
219
36.08%
AtriCureOutperform Votes
561
69.17%
Underperform Votes
250
30.83%

Integer has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500. Comparatively, AtriCure has a beta of 1.42, meaning that its stock price is 42% more volatile than the S&P 500.

Integer has a net margin of 6.70% compared to AtriCure's net margin of -8.70%. Integer's return on equity of 11.63% beat AtriCure's return on equity.

Company Net Margins Return on Equity Return on Assets
Integer6.70% 11.63% 5.86%
AtriCure -8.70%-8.12%-6.21%

In the previous week, AtriCure had 15 more articles in the media than Integer. MarketBeat recorded 16 mentions for AtriCure and 1 mentions for Integer. Integer's average media sentiment score of 0.76 beat AtriCure's score of 0.46 indicating that Integer is being referred to more favorably in the media.

Company Overall Sentiment
Integer Positive
AtriCure Neutral

Integer has higher revenue and earnings than AtriCure. AtriCure is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Integer$1.60B2.96$90.65M$3.2443.49
AtriCure$399.24M4.70-$30.44M-$0.83-46.35

Summary

Integer beats AtriCure on 9 of the 17 factors compared between the two stocks.

Get AtriCure News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATRC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ATRC vs. The Competition

MetricAtriCureSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$1.53B$4.51B$5.22B$8.94B
Dividend YieldN/A47.30%5.13%4.04%
P/E Ratio-46.3526.2989.7217.34
Price / Sales4.7058.321,251.2178.56
Price / CashN/A50.1443.8235.97
Price / Book3.917.795.324.79
Net Income-$30.44M$13.87M$122.69M$225.00M
7 Day Performance22.48%1.46%-0.16%1.52%
1 Month Performance27.17%11.95%3.75%4.68%
1 Year Performance16.58%53.01%27.41%20.89%

AtriCure Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATRC
AtriCure
1.9181 of 5 stars
$38.47
+2.2%
$42.00
+9.2%
+15.1%$1.53B$399.24M-46.351,200High Trading Volume
ITGR
Integer
2.7648 of 5 stars
$134.84
+0.8%
$145.44
+7.9%
+35.5%$4.52B$1.71B41.6210,500
IART
Integra LifeSciences
3.5318 of 5 stars
$22.30
+2.2%
$23.00
+3.1%
-42.5%$1.72B$1.56B-247.753,946Short Interest ↓
ATEC
Alphatec
4.4361 of 5 stars
$10.95
+9.8%
$17.44
+59.3%
-23.4%$1.55B$572.74M-8.55700Analyst Forecast
Insider Trade
High Trading Volume
OFIX
Orthofix Medical
2.7242 of 5 stars
$17.29
+1.7%
$23.00
+33.0%
+36.3%$660.72M$784.25M-5.521,090Insider Trade
News Coverage
SRDX
Surmodics
4.2277 of 5 stars
$36.02
-6.3%
$50.00
+38.8%
+10.3%$514.87M$126.08M-44.47450Analyst Forecast
News Coverage
ANGO
AngioDynamics
4.0079 of 5 stars
$12.47
+1.4%
$13.00
+4.3%
+111.0%$506.71M$292.73M-2.05760Short Interest ↓
News Coverage
Gap Down
ARAY
Accuray
4.4617 of 5 stars
$2.20
+2.8%
$9.00
+309.1%
-19.4%$221.24M$444.20M-12.941,040Short Interest ↑
RMTI
Rockwell Medical
4.3251 of 5 stars
$2.04
-1.9%
$6.00
+194.1%
+47.2%$65.93M$98.92M-40.80300Short Interest ↓
News Coverage
Positive News
RSLS
ReShape Lifesciences
1.1526 of 5 stars
$5.11
+13.6%
N/A-65.5%$3.64M$8.18M0.0050Short Interest ↓
Positive News
Gap Up
High Trading Volume
ABT
Abbott Laboratories
4.7556 of 5 stars
$112.98
+0.6%
$131.57
+16.5%
-0.4%$195.96B$41.22B34.34115,000Options Volume
News Coverage

Related Companies and Tools


This page (NASDAQ:ATRC) was last updated on 1/18/2025 by MarketBeat.com Staff
From Our Partners